Aldeyra Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALDX and other ETFs, options, and stocks.

About ALDX

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. 

CEO
Todd C. Brady
CEOTodd C. Brady
Employees
9
Employees9
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2004
Founded2004
Employees
9
Employees9

ALDX Key Statistics

Market cap
307.73M
Market cap307.73M
Price-Earnings ratio
-7.23
Price-Earnings ratio-7.23
Dividend yield
Dividend yield
Average volume
857.35K
Average volume857.35K
High today
$5.43
High today$5.43
Low today
$5.02
Low today$5.02
Open price
$5.21
Open price$5.21
Volume
722.58K
Volume722.58K
52 Week high
$7.20
52 Week high$7.20
52 Week low
$1.14
52 Week low$1.14

Stock Snapshot

Aldeyra Therapeutics(ALDX) stock is priced at $5.12, giving the company a market capitalization of 307.73M. It carries a P/E multiple of -7.23.

On 2026-01-23, Aldeyra Therapeutics(ALDX) stock traded between a low of $5.02 and a high of $5.43. Shares are currently priced at $5.12, which is +1.9% above the low and -5.8% below the high.

Aldeyra Therapeutics(ALDX) shares are trading with a volume of 722.58K, against a daily average of 857.35K.

During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.14 at its lowest and $7.20 at its peak.

During the past year, Aldeyra Therapeutics(ALDX) stock moved between $1.14 at its lowest and $7.20 at its peak.

ALDX News

Simply Wall St 3d
ATA Creativity Global Among 3 Promising Penny Stocks

As the U.S. stock market faces a challenging period with major indexes posting weekly losses and Treasury yields reaching a four-month high, investors are keenl...

ATA Creativity Global Among 3 Promising Penny Stocks
Simply Wall St 5d
Following a 4.3% decline over last year, recent gains may please Aldeyra Therapeutics, Inc. institutional owners

Advertisement Key Insights Significantly high institutional ownership implies Aldeyra Therapeutics' stock price is sensitive to their trading actions A total...

Following a 4.3% decline over last year, recent gains may please Aldeyra Therapeutics, Inc. institutional owners

People also own

Based on the portfolios of people who own ALDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 companies by market cap and showing a subset from that 100.

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.